Follistatin 344 Dosage & Reconstitution Guide (Muscle Growth Peptide Explained)
Follistatin 344
Follistatin 344 is a peptide studied for its role in muscle growth, recovery, and myostatin inhibition. It is commonly discussed in performance and physique-focused protocols due to its ability to reduce myostatin activity, a signaling protein that limits muscle growth.
How It Works
Myostatin Inhibition → Muscle Growth ↑ → Recovery ↑ → Muscle Breakdown ↓
Follistatin 344 is studied for its ability to bind and inhibit myostatin, which may allow for greater muscle growth potential and improved recovery support.
Follistatin 344 Protocol
Standard Range
Dose100 mcg daily
Units20 units
Volume0.20 mL
Cycle Length
Typical Use10–30 days
Frequency: Once daily
Timing: Morning or post-workout
Route: Subcutaneous
Cycle Length: 10–30 days
Advanced Range
Low Range50 mcg (10 units)
Moderate100 mcg (20 units)
Higher Range200 mcg (40 units)
When & Where to Inject
- Subcutaneous injection
- Abdomen, thigh, or upper arm
- Use a consistent time daily
- Rotate injection sites regularly
Reconstitution & Dosing (1 mg Vial)
Vial
1 mg
Water
2.0 mL
Concentration
0.5 mg/mL
Conversion
1 unit = 5 mcg
Dose Reference
10 units = 50 mcg
20 units = 100 mcg
40 units = 200 mcg
Reconstitution Steps
Draw 2.0 mL bacteriostatic water
Inject slowly into the vial
Gently swirl (do not shake)
Allow powder to fully dissolve
Storage
Refrigerate at 2–8°C after reconstitution
Do not freeze after mixing
Use within 30 days
Monitoring During Use
- Muscle fullness and recovery
- Strength progression
- Training performance
- Injection site tolerance
Benefits
- Supports myostatin inhibition
- May enhance muscle growth potential
- May improve recovery from training
- Often discussed in physique-focused protocols
Potential Side Effects
- Mild injection site irritation
- Limited human data
- Response may vary significantly
Important Notes
- Short cycles are commonly discussed
- Human data is limited
- Often used in muscle-focused discussions
- Best approached conservatively
Important Disclaimer
Follistatin 344 is an investigational compound and is not FDA-approved. This content is for educational and research purposes only.
Peptide Directory →
Comments
Post a Comment